Bisphenol A exposure affects specific gut taxa and drives microbiota dynamics in childhood obesity.

Cumulative xenobiotic exposure has an environmental and human health impact which is currently assessed under the One Health approach. Bisphenol A (BPA) exposure and its potential link with childhood obesity that has parallelly increased during the last decades deserve special attention. It stands during prenatal or early life and could trigger comorbidities and non-communicable diseases along life. Accumulation in the nature of synthetic chemicals supports the "environmental obesogen" hypothesis, such as BPA. This estrogen-mimicking xenobiotic has shown endocrine disruptive and obesogenic effects accompanied by gut microbiota misbalance that is not yet well elucidated. This study aimed to investigate specific microbiota taxa isolated and selected by direct BPA exposure and reveal its role on the overall children microbiota community and dynamics, driving toward specific obesity dysbiosis. A total of 333 BPA-resistant isolated species obtained through culturing after several exposure conditions were evaluated for their role and interplay with the global microbial community. The selected BPA-cultured taxa biomarkers showed a significant impact on alpha diversity. Specifically, Clostridium and Romboutsia were positively associated promoting the richness of microbiota communities, while Intestinibacter, Escherichia-Shigella, Bifidobacterium, and Lactobacillus were negatively associated. Microbial community dynamics and networks analyses showed differences according to the study groups. The normal-weight children group exhibited a more enriched, structured, and connected taxa network compared to overweight and obese groups, which could represent a more resilient community to xenobiotic substances. In this sense, subnetwork analysis generated with the BPA-cultured genera showed a correlation between taxa connectivity and more diverse potential enzymatic BPA degradation capacities.IMPORTANCEOur findings indicate how gut microbiota taxa with the capacity to grow in BPA were differentially represented within differential body mass index children study groups and how these taxa affected the overall dynamics toward patterns of diversity generally recognized in dysbiosis. Community network and subnetwork analyses corroborated the better connectedness and stability profiles for normal-weight group compared to the overweight and obese groups.

Microbiota analysis for risk assessment of xenobiotic exposure and the impact on dysbiosis: identifying potential next-generation probiotics.

On-going projects of the team are currently dealing with microbiota, xenobiotics, endocrine-disrupting chemicals (EDCs), obesity, inflammation and probiotics. The combination of diet, lifestyle and the exposure to dietary xenobiotics categorised into microbiota-disrupting chemicals (MDCs) could determine obesogenic-related dysbiosis. This modification of the microbiota diversity impacts on individual health-disease balance, inducing altered phenotypes. Specific, complementary, and combined prevention and treatments are needed to face these altered microbial patterns and the specific misbalances triggered. In this sense, searching for next-generation probiotics (NGP) by microbiota culturing, and focusing on their demonstrated, extensive scope and well-defined functions could contribute to counteracting and repairing the effects of obesogens. Therefore, EU-FORA project contributes to present a perspective through compiling information and key strategies for directed taxa searching and culturing of NGP that could be administered for preventing obesity and endocrine-related dysbiosis by (i) observing the differential abundance of specific microbiota taxa in obesity-related patients and analysing their functional roles, (ii) developing microbiota-directed strategies for culturing these taxa groups, and (iii) design and applying the successful compiled criteria from recent NGP clinical studies. New isolated or cultivable microorganisms from healthy gut microbiota specifically related to xenobiotic obesogens' neutralisation effects might be used as an NGP single strain or in consortia, both presenting functions and the ability to palliate metabolic-related disorders. Identification of holistic approaches for searching and using potential NGP, key aspects, the bias, gaps and proposals of solutions were also considered in this workplan.

Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health.

Three areas of relevance to the gut microbiome in the context of One Health were explored; the incorporation of the microbiome in food safety risk assessment of xenobiotics; the identification and application of beneficial microbial components to various areas under One Health, and; specifically, in the context of antimicrobial resistance. Although challenging, focusing on the microbiota resilience, function and active components is critical for advancing the incorporation of microbiome data in the risk assessment of xenobiotics. Moreover, the human microbiota may be a promising source of beneficial components, with the potential to metabolize xenobiotics. These may have possible applications in several areas, e.g., in animals or plants for detoxification or in the environment for biodegradation. This approach would be of particular interest for antimicrobials, with the potential to ameliorate antimicrobial resistance development. Finally, the concept of resistance to xenobiotics in the context of the gut microbiome may deserve further investigation.

Juvenile Hemochromatosis due to a Homozygous Variant in the HJV Gene.

Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes, osteopathic medicine, and thyroid abnormality, before age of 30. Juvenile hemochromatosis type 2a and 2b is an autosomal recessive disease caused by pathogenic variants in HJV and HAMP genes, respectively. We report a child with hepatic iron overload and family history of hemochromatosis. We aim to raise awareness of juvenile hemochromatosis, especially in families with a positive family history, as early diagnosis and treatment may prevent organ involvement and end-stage disease. The purpose of this study was to identify the gene variant that causes the disease. The genetic study was performed with a targeted gene panel: HFE, HJV, HAMP, TFR2, SLC40A1, FTL, and FTH1. We identified the variant c.309C > G (p.Phe103Leu) in the HJV gene in the homozygous state in the patient.

Impact of Cumulative Environmental and Dietary Xenobiotics on Human Microbiota: Risk Assessment for One Health.

Chemical risk assessment in the context of the risk analysis framework was initially designed to evaluate the impact of hazardous substances or xenobiotics on human health. As the need of multiple stressors assessment was revealed to be more reliable regarding the occurrence and severity of the adverse effects in the exposed organisms, the cumulative risk assessment started to be the recommended approach. As toxicant mixtures and their "cocktail effects" are considered to be main hazards, the most important exposure for these xenobiotics would be of dietary and environmental origin. In fact, even a more holistic prism should currently be considered. In this sense, the definition of One Health refers to simultaneous actions for improving human, animal, and environmental health through transdisciplinary cooperation. Global policies necessitate going beyond the classical risk assessment for guaranteeing human health through actions and implementation of the One Health approach. In this context, a new perspective is proposed for the integration of microbiome biomarkers and next generation probiotics potentially impacting and modulating not only human health, but plant, animal health, and the environment.

Culturing and Molecular Approaches for Identifying Microbiota Taxa Impacting Children's Obesogenic Phenotypes Related to Xenobiotic Dietary Exposure.

Integrated data from molecular and improved culturomics studies might offer holistic insights on gut microbiome dysbiosis triggered by xenobiotics, such as obesity and metabolic disorders. Bisphenol A (BPA), a dietary xenobiotic obesogen, was chosen for a directed culturing approach using microbiota specimens from 46 children with obesity and normal-weight profiles. In parallel, a complementary molecular analysis was carried out to estimate the BPA metabolising capacities. Firstly, catalogues of 237 BPA directed-cultured microorganisms were isolated using five selected media and several BPA treatments and conditions. Taxa from Firmicutes, Proteobacteria, and Actinobacteria were the most abundant in normal-weight and overweight/obese children, with species belonging to the genera Enterococcus, Escherichia, Staphylococcus, Bacillus, and Clostridium. Secondly, the representative isolated taxa from normal-weight vs. overweight/obese were grouped as BPA biodegrader, tolerant, or resistant bacteria, according to the presence of genes encoding BPA enzymes in their whole genome sequences. Remarkably, the presence of sporobiota and concretely Bacillus spp. showed the higher BPA biodegradation potential in overweight/obese group compared to normal-weight, which could drive a relevant role in obesity and metabolic dysbiosis triggered by these xenobiotics.

Rapid and simultaneous determination of histidine metabolism intermediates in human and mouse microbiota and biomatrices.

Histidine metabolism is a key pathway physiologically involved in satiety, recognition memory, skin, and neural protection and allergic diseases. Microbiologically-produced imidazole propionate induces type II diabetes and interferes with glucose lowering drugs. Despite their determinant health implications, no single method simultaneously assesses histidine metabolites in urine, feces, and microbiota. The aim of this study was to develop a simple, rapid, and sensitive method for the determination of histidine and its major bioactive metabolites histamine, N-acetylhistamine, imidazole-4-acetate, cis-urocanate, trans-urocanate, glutamate and imidazole propionate, using ultrahigh-performance liquid chromatography with electrospray ionization tandem mass spectrometry. An innovative simple extraction method from small aliquots of human and mice urine, feces and microbial cell extracts was coupled to separation in a 6.5 min chromatographic run. The successful performance allowed accurate and precise quantification of all metabolites in mouse feces, suggesting broad exchange of histidine metabolites between the gut and mice. Higher urine histamine, histamine to histidine ratio, and imidazole-4-acetate pointed to an underlying inflammatory or allergic process in mice compared to human subjects. N-acetylhistamine and imidazole propionate were detected in human and mouse feces, confirming its origin from gut microbial metabolism. Our novel and robust analytical method captured histidine metabolism in a single assay that will facilitate broad and deep histidine metabolic phenotyping assessing the impact of microbiota on host health in large-scale human observational and interventional studies.

Antimicrobial Effects of Potential Probiotics of Bacillus spp. Isolated from Human Microbiota: In Vitro and In Silico Methods.

The variable taxa components of human gut microbiota seem to have an enormous biotechnological potential that is not yet well explored. To investigate the usefulness and applications of its biocompounds and/or bioactive substances would have a dual impact, allowing us to better understand the ecology of these microbiota consortia and to obtain resources for extended uses. Our research team has obtained a catalogue of isolated and typified strains from microbiota showing resistance to dietary contaminants and obesogens. Special attention was paid to cultivable Bacillus species as potential next-generation probiotics (NGP) together with their antimicrobial production and ecological impacts. The objective of the present work focused on bioinformatic genome data mining and phenotypic analyses for antimicrobial production. In silico methods were applied over the phylogenetically closest type strain genomes of the microbiota Bacillus spp. isolates and standardized antimicrobial production procedures were used. The main results showed partial and complete gene identification and presence of polyketide (PK) clusters on the whole genome sequences (WGS) analysed. Moreover, specific antimicrobial effects against B. cereus, B. circulans, Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Serratia marcescens, Klebsiella spp., Pseudomonas spp., and Salmonella spp. confirmed their capacity of antimicrobial production. In conclusion, Bacillus strains isolated from human gut microbiota and taxonomic group, resistant to Bisphenols as xenobiotics type endocrine disruptors, showed parallel PKS biosynthesis and a phenotypic antimicrobial effect. This could modulate the composition of human gut microbiota and therefore its functionalities, becoming a predominant group when high contaminant exposure conditions are present.

Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies.

The combination of diet, lifestyle, and the exposure to food obesogens categorized into "microbiota disrupting chemicals" (MDC) could determine obesogenic-related dysbiosis and modify the microbiota diversity that impacts on individual health-disease balances, inducing altered pathogenesis phenotypes. Specific, complementary, and combined treatments are needed to face these altered microbial patterns and the specific misbalances triggered. In this sense, searching for next-generation beneficial microbes or next-generation probiotics (NGP) by microbiota culturing, and focusing on their demonstrated, extensive scope and well-defined functions could contribute to counteracting and repairing the effects of obesogens. Therefore, this review presents a perspective through compiling information and key strategies for directed searching and culturing of NGP that could be administered for obesity and endocrine-related dysbiosis by (i) observing the differential abundance of specific microbiota taxa in obesity-related patients and analyzing their functional roles, (ii) developing microbiota-directed strategies for culturing these taxa groups, and (iii) applying the successful compiled criteria from recent NGP clinical studies. New isolated or cultivable microorganisms from healthy gut microbiota specifically related to obesogens' neutralization effects might be used as an NGP single strain or in consortia, both presenting functions and the ability to palliate metabolic-related disorders. Identification of holistic approaches for searching and using potential NGP, key aspects, the bias, gaps, and proposals of solutions are also considered in this review.

Representative Bacillus sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation.

Human gut microbiota harbors numerous microbial species with molecular enzymatic potential that impact on the eubiosis/dysbiosis and health/disease balances. Microbiota species isolation and description of their specific molecular features remain largely unexplored. In the present study, we focused on the cultivation and selection of species able to tolerate or biodegrade the endocrine disruptor bisphenol A (BPA), a xenobiotic extensively found in food plastic containers. Chemical xenobiotic addition methods for the directed isolation, culturing, Whole Genome Sequencing (WGS), phylogenomic identification, and specific gene-encoding searches have been applied to isolate microorganisms, assess their BPA metabolization potential, and describe encoded catabolic pathways. BPA-tolerant strains were isolated from 30% of infant fecal microbial culture libraries analyzed. Most isolated strains were phylogenetically related to the operational taxonomic group Bacillus amyloliquefaciens spp. Importantly, WGS analysis of microbial representative strain, Bacillus sp. AM1 identified the four complete molecular pathways involved on BPA degradation indicating its versatility and high potential to degrade BPA. Pathways for Exopolysaccharide (EPS) and Polyhydroxyalkanates (PHA) biopolymer synthesis were also identified and phenotypically confirmed by transmission electronic microscopy (TEM). These microbial biopolymers could generally contribute to capture and/or deposit xenobiotics.

Infant Gut Microbiota Associated with Fine Motor Skills.

BACKGROUND: During early life, dynamic gut colonization and brain development co-occur with potential cross-talk mechanisms affecting behaviour. METHODS: We used 16S rRNA gene sequencing to examine the associations between gut microbiota and neurodevelopmental outcomes assessed by the Bayley Scales of Infant Development III in 71 full-term healthy infants at 18 months of age. We hypothesized that children would differ in gut microbial diversity, enterotypes obtained by Dirichlet multinomial mixture analysis and specific taxa based on their behavioural characteristics. RESULTS: In children dichotomized by behavioural trait performance in above- and below-median groups, weighted Unifrac b-diversity exhibited significant differences in fine motor (FM) activity. Dirichlet multinomial mixture modelling identified two enterotypes strongly associated with FM outcomes. When controlling for maternal pre-gestational BMI and breastfeeding for up to 3 months, the examination of signature taxa in FM groups showed that Turicibacter and Parabacteroides were highly abundant in the below-median FM group, while Collinsella, Coprococcus, Enterococcus, Fusobacterium, Holdemanella, Propionibacterium, Roseburia, Veillonella, an unassigned genus within Veillonellaceae and, interestingly, probiotic Bifidobacterium and Lactobacillus were more abundant in the above-median FM group. CONCLUSIONS: Our results suggest an association between enterotypes and specific genera with FM activity and may represent an opportunity for probiotic interventions relevant to treatment for motor disorders.

Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis.

The use of probiotics in reproductive-related dysbiosis is an area of continuous progress due to the growing interest from clinicians and patients suffering from recurrent reproductive microbiota disorders. An imbalance in the natural colonization sites related to reproductive health-vaginal, cervicovaginal, endometrial, and pregnancy-related altered microbiota-could play a decisive role in reproductive outcomes. Oral and vaginal administrations are in continuous discussion regarding the clinical effects pursued, but the oral route is used and studied more often despite the need for further transference to the colonization site. The aim of the present review was to retrieve the standardized protocols of vaginal probiotics commonly used for investigating their microbiota modulation capacities. Most of the studies selected focused on treating bacterial vaginosis (BV) as the most common dysbiosis; a few studies focused on vulvovaginal candidiasis (VVC) and on pretreatment during in vitro fertilization (IVF). Vaginal probiotic doses administered were similar to oral probiotics protocols, ranging from ≥107 CFU/day to 2.5 × 1010 CFU/day, but were highly variable regarding the treatment duration timing. Moderate vaginal microbiota modulation was achieved; the relative abundance of abnormal microbiota decreased and Lactobacillus species increased.

Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis.

Obesity is a growing health threat worldwide. Administration of probiotics in obesity has also parallelly increased but without any protocolization. We conducted a systematic review exploring the administration pattern of probiotic strains and effective doses for obesity-related disorders according to their capacity of positively modulating key biomarkers and microbiota dysbiosis. Manuscripts targeting probiotic strains and doses administered for obesity-related disorders in clinical studies were sought. MEDLINE, Scopus, Web of Science, and Cochrane Library databases were searched using keywords during the last fifteen years up to April 2020. Two independent reviewers screened titles, abstracts, and then full-text papers against inclusion criteria according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. From 549 interventional reports identified, we filtered 171 eligible studies, from which 24 full-text assays were used for calculating intervention total doses (ITD) of specific species and strains administered. Nine of these reports were excluded in the second-step because no specific data on gut microbiota modulation was found. Six clinical trials (CT) and 9 animal clinical studies were retained for analysis of complete outcome prioritized (body mass index (BMI), adiposity parameters, glucose, and plasma lipid biomarkers, and gut hormones). Lactobacillus spp. administered were double compared to Bifidobacterium spp.; Lactobacillus as single or multispecies formulations whereas most Bifidobacteria only through multispecies supplementations. Differential factors were estimated from obese populations' vs. obesity-induced animals: ITD ratio of 2 × 106 CFU and patterns of administrations of 11.3 weeks to 5.5 weeks, respectively. Estimation of overall probiotics impact from selected CT was performed through a random-effects model to pool effect sizes. Comparisons showed a positive association between the probiotics group vs. placebo on the reduction of BMI, total cholesterol, leptin, and adiponectin. Moreover, negative estimation appeared for glucose (FPG) and CRP. While clinical trials including data for positive modulatory microbiota capacities suggested that high doses of common single and multispecies of Lactobacillus and Bifidobacterium ameliorated key obesity-related parameters, the major limitation was the high variability between studies and lack of standardized protocols. Efforts in solving this problem and searching for next-generation probiotics for obesity-related diseases would highly improve the rational use of probiotics.

Probióticos y disbiosis de fertilidad / Probiotics and dysbiosis in fertility

El uso de probióticos es un área de investigación traslacional en continuo progreso debido al creciente interés de los clínicos del área de fertilidad y sus pacientes. Por lo que el objetivo principal de este trabajo es recabar y resumir la información de la literatura científica relevante sobre los probióticos y su posible papel modulador efectivo en alteraciones relacionadas con la fertilidad y reproductivas. Para ello se describen los aspectos de interés relativos a: 1. La microbiota humana y sitios naturales de colonización relacionados con la salud reproductiva: microbiota vaginal, microbiota endometrial, microbiota y embarazo. 2. A continuación, hemos resaltado las disbiosis de los sitios de colonización y las repercusiones en fertilidad del estado de salud/enfermedad y por último 3. La hipótesis sobre los tratamientos efectivos con probióticos orales vs vaginales y sus vías fisiológicas de transferencia y actuación; que lleva asociado la descripción del concepto de translocación efectiva o llegada de los probióticos alsitio natural de colonización tras su administración como suplementos. La mayoría de probióticos utilizados en disbiosis relacionadas con la fertilidad pertenecen al género Lactobacillus. Se suelen administrar principalmente por vía oral a una concentración del orden de 1x109UFC/día y una duración de4-12 semanas, siendo diferencial en función de la disbiosis a tratar

The use of probiotics is an area of translational research in continuous progress due to the growing interest of fertility clinicians and their patients. Therefore, the main objective of this work is to collect and summarise relevant information from the available scientific literature on probiotics and their effective modulating role in fertility-related and reproductive disorders. To approach this objective, we have summarised the knowledge regarding the following pertinent aspects: 1. The human microbiota: intestinal microbiota already well studied, and other natural colonization sites related to reproductive health: vaginal microbiota, endometrial microbiota, pregnancy microbiota. 2. Next, we have highlighted the dysbiosis of the colonization sites and the repercussions on the state of health / disease and finally 3. The hypothesis that exists about effective treatments with oral probiotics and their physiological transfer and performance pathways and the associated concept of translocation or arrival at the natural site of colonization. Most probiotics used in fertility-related dysbiosis be-long to the genus Lactobacillus. They are mainly administered via oral at average concentrations of 1x109CFU/day during 4-12 weeks, being differential depending on the dysbiosis to be treated

Probiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosis.

Human microbiota seems to play a key role in endocrine and reproductive systems. Fortunately, microbiota reproductive dysbiosis start to be treated by probiotics using typical species from genus Lactobacillus. This work presents the compiled and analysed results from the most up-to-date information from clinical trials regarding microbiota, fertility, probiotics and oral route administration, reviewing open access scientific documents. These studies analyse the clinical impact of probiotics administered on several endocrine disorders' manifestations in women: mastitis; vaginal dysbiosis; pregnancy complication disorders; and polycystic ovary syndrome. In all cases, the clinical modulation achieved by probiotics was evaluated positively through the improvement of specific disease outcomes with the exception of the pregnancy disorders studies, where the sample sizes results were statistically insufficient. High amounts of studies were discarded because no data were provided on specific probiotic strains, doses, impact on the individual autochthon microbiota, or data regarding specific hormonal values modifications and endocrine regulation effects. However, most of the selected studies with probiotics contained no protocolised administration. Therefore, we consider that intervention studies with probiotics might allocate the focus, not only in obtaining a final outcome, but in how to personalise the administration according to the disorder to be palliated.

How far do adult turtles move? Home range and dispersal of Kinosternon integrum.

We describe the home range and movements of a population of Kinosternon integrum in Tonatico, Estado de México, México, over 3.5 years (during rainy and dry season months) using radiotelemetry in 37 adult turtles. The results showed that the home range of K. integrum was 0.151 ± 0.051 ha using 50% kernel density estimator (KDE), and 0.657 ± 0.214 ha using 95% KDE; the home range did not vary between sexes. Kinosternon integrum showed low distances traveled 51.44 ± 4.50 m, where 87.3% (n = 373) of movements were <100 m. The distance traveled differed by season, and movement category (aquatic and terrestrial movements). The shortest distance occurred during the dry season, during which some individuals move to estivation sites, and these movements were shorter than movements to artificial ponds (cattle ponds). In this population, home range and movement are similar to other species of the genus Kinosternon. Overall, the results indicate than K. integrum are highly dependent on aquatic habitats, but also utilize the terrestrial habitats for different biological activities, and to maintain viable populations. Therefore, the conservation of the entire inhabited area is fundamental. This study highlights the need to increase the studies, in Central México, concerning habitat use of freshwater turtles in order to increase the efficiency of conservation strategies.

[Home range of Aspidoscelis cozumela (Squamata: Teiidae): a parthenogenetic lizard microendemic to Cozumel Island, México]. / Ámbito hogareño de Aspidoscelis cozumela (Squamata, Teiidae): una lagartija partenogenética microendémica de Isla Cozumel, México.

Home range is defined as the area within which an individual moves to acquire resources necessary to increase their fitness and may vary inter and intra-specifically with biotic and abiotic factors. This study details the home range of the parthenogenic lizard, Aspidoscelis cozumela, an active forager microendemic to Cozumel Island, México, with high preference for open sand beaches. The home range of A. cozumela was compared with other species of Aspidoscelis (gonochoric and parthenogenetic) and other lizards that occupy coastal habitats. Furthermore, the biotic and abiotic factors that may influence home range were analyzed. This study was conducted in the beach located on the East side of the island (area of 4,000 M2) that is composed primarily of halophyte vegetation with high levels of sunlight. From 1999 to 2001, nine samples were taken which included the dry, rainy, "nortes", and breeding seasons. During each sampling, capture-mark-recapture techniques were conducted and the date, time of day, and snout-vent length (SVL) were recorded to the nearest millimeter. Individuals were located in the study area using a bi-coordinate reference using 10 x 10 m subdivisions of the habitat. Home range and home range overlap were calculated using the convex polygon method in McPaal and home range/SVL correlation was tested using Pearson's correlation. To calculate females home range, three or more recaptures were considered. A total of 20 home ranges that averaged 45.1 ± 14.0 m2 were obtained and no correlation between SVL and home range size was detected (p = 0.9229, n = 20). However, removing individuals with outlier home ranges (females with home ranges > 100 m2, n = 2) resulted in a positive correlation with SVL (r = 0.61, p = 0.0072, n = 18). A 22.9 ± 5.7% overlap in home range was also detected. The small home range of A. cozumela represents the smallest home range within the Aspidoscelis genus recorded to date (including both parthenogenetic and gonochoric species) and contrasts the theoretical predictions of broad home ranges for widely foraging species. Thermoregulatory benefits and a high population density may explain the small home range of A. cozumela. Although this species is highly adapted to the environmental conditions present on the open sand beaches, anthropogenic effects on these habitats by the development of tourism infrastructure may jeopardize their existence on Cozumel Island.

Ámbito hogareño de Aspidoscelis cozumela(Squamata, Teiidae): una lagartija partenogenética microendémica de Isla Cozumel, México / Home range of Aspidoscelis cozumela (Squamata: Teiidae): a parthenogenetic lizard microen-demic to Cozumel Island, México

Home range is defined as the area within which an individual moves to acquire resources necessary to increase their fitness and may vary inter and intra-specifically with biotic and abiotic factors. This study details the home range of the parthenogenic lizard, Aspidoscelis cozumela,an active forager microendemic to Cozumel Island, México, with high preference for open sand beaches. The home range of A. cozumelawas compared with other species of Aspidoscelis(gonochoric and parthenogenetic) and other lizards that occupy coastal habitats. Furthermore, the biotic and abiotic factors that may influence home range were analyzed. This study was conducted in the beach located on the East side of the island (area of 4 000 m2) that is composed primarily of halophyte vegetation with high levels of sunlight. From 1999 to 2001, nine samples were taken which included the dry, rainy, "nortes", and breeding seasons. During each sampling, capture-mark-recapture techniques were conducted and the date, time of day, and snout-vent length (SVL) were recorded to the nearest millimeter. Individuals were located in the study area using a bi-coordinate reference using 10 x 10 m subdivisions of the habitat. Home range and home range overlap were calculated using the convex polygon method in McPaal and home range/SVL correlation was tested using Pearson's correlation. To calculate females home range, three or more recaptures were considered. A total of 20 home ranges that averaged 45.1 ± 14.0 m2 were obtained and no correlation between SVL and home range size was detected (p = 0.9229, n = 20). However, removing individuals with outlier home ranges (females with home ranges > 100 m2, n = 2) resulted in a positive correlation with SVL (r = 0.61, p = 0.0072, n = 18). A 22.9 ± 5.7% overlap in home range was also detected. The small home range of A. cozumelarepresents the smallest home range within the Aspidoscelisgenus recorded to date (including both parthenogenetic and gonochoric species) and contrasts the theoretical predictions of broad home ranges for widely foraging species. Thermoregulatory benefits and a high population density may explain the small home range of A. cozumela.Although this species is highly adapted to the environmental conditions present on the open sand beaches, anthropogenic effects on these habitats by the development of tourism infrastructure may jeopardize their existence on Cozumel Island.

El ámbito hogareño es el área dentro de la cual un individuo se mueve para adquirir recursos que incrementen su supervivencia. El ámbito hogareño puede variar, intra e interespecíficamente, por factores bióticos y abióticos. En este trabajo se estudió el ámbito hogareño de la lagartija partenogenética Aspidoscelis cozumela,una especie de forrajeo amplio, con alta preferencia por las playas y microendémica de Isla Cozumel, México. El ámbito hogareño de A. cozumelase comparó con otras especies de Aspidoscelis(gonocóricas y partenogenéticas) y con otras lagartijas que ocupan hábitats costeros. Además, se discuten los factores bióticos y abióticos que lo moldean. La zona de estudio fue una playa (con un área de 4 000 m2), que se encuentra al Este de la isla y que presenta vegetación halófita (expuesta a altos niveles de insolación). De 1999 al 2001 se realizaron nueve censos que cubrieron la época de sequía, de lluvias y la época de "nortes" de la zona y la temporada de reproducción de A. cozumela.Durante cada censo, se realizó captura-marcaje-recaptura y se registró: fecha, hora del día, longitud hocico-cloaca (LHC) al milímetro más cercano. Los individuos fueron ubicados en el área de estudio por bi-coordenadas usando estacas como referencia. El ámbito hogareño se calculó con el método del polígono convexo con el programa McPaal, adicional-mente se calculó el solapamiento del ámbito hogareño. Se relacionó la LHC con el ámbito hogareño. Para el cálculo del ámbito hogareño se consideraron las hembras con tres o más recapturas. Se obtuvieron 20 ámbitos hogareños, que promediaron 45.1 ± 14.0 m2. No se encontró relación de la LHC con el ámbito hogareño (p = 0.9229, n = 20). Sin embargo, un análisis que excluyó los individuos con los ámbitos hogareños extremos, mostró que el ámbito hogareño de A. cozumelase relacionó de manera positiva con la LHC (p = 0.0072, n = 18), las hembras más grandes tuvieron ámbitos hogareños más amplios. El solapamiento del ámbito hogareño fue de 22.9 ± 5.7%. El ámbito hogareño de A. cozumelaes el más pequeño que se ha documentado en el género Aspidoscelis(incluyendo especies partenoge-néticas y gonocóricas) y se contrapone con las predicciones teóricas que establecen ámbitos hogareños amplios para especies de forrajeo amplio. Beneficios térmicos y una elevada densidad poblacional pueden explicar la marcada residencia en las playas y ámbito hogareño reducido de A. cozumela.La lagartija partenogenética A. cozumelaestá bien adaptada a las condiciones ambientales en las playas, sin embargo las afectaciones severas en las playas por el desarrollo de la infraestructura turística pueden poner en riesgo su existencia en Isla Cozumel.